Category: announcements


August 25, 2011

FDA to Hold Public Town Hall Discussion in San Francisco

The 23andMe Blog

In March earlier this year, 23andMe presented its views on possible federal regulation of the direct-to-consumer (DTC) genetic testing industry at an Advisory Committee meeting convened by the FDA. We reiterated our belief that individuals have a right to access their own genetic information without physician [...]

Read more…

July 26, 2011

Roots into the Future: A New 23andMe Research Initiative For African Americans

RootsLogo

http://www.youtube.com/watch?v=kTYFNwxl3Pw A recent article in Wired Magazine highlighted how the genome revolution has been skipping most people in the world: 96% of participants in recent genomic studies trace most of their ancestry to Europe. Why? Statistical analysis is simpler in groups tracing [...]

Read more…

June 23, 2011

23andMe Publishes Parkinson’s Paper Identifying Two Novel Genetic Associations

logopng

On the eve of the anniversary of our first publication, 23andMe is excited to announce the publication of our second research paper, "Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson’s disease", posted online today in PLoS Genetics. This [...]

Read more…

June 16, 2011

23andMe Research Findings: From You, Back to You

istock-throatpain-cropped

It’s been nearly a year since we published our first scientific paper. Titled “Web-based, Participant-Driven Studies Yield Novel Genetic Associations for Common Traits,” the paper demonstrated that 23andWe, our revolutionary new research model, works. Since then we’ve been making exciting progress, [...]

Read more…

June 15, 2011

23andMe 2011 State of the Database Address

100000_ascii

Database Snapshot: 100,611 users genotyped 76% have agreed to participate in research 59% take surveys 57% are male 47% are sharing with other users 12% have multiple ancestry 45 is the average age 100,409 posts in our community forums 60,000 pairs of relatives among users (4th [...]

Read more…

May 10, 2011

Sarcoma Community Update

sarcoma image

Genetic research is a numbers game. The more people who contribute to the effort, the more powerful it gets. As our Sarcoma Community grows with survey responses and genetic data from participants, we learn more about sarcoma and people’s responses to treatment. We are over halfway to our goal of 1,000 [...]

Read more…

April 29, 2011

Cinco de Me-O

l.tif

The typical five year-old is pretty confident, filled with energy and imagination. Maybe a little loud. Yesterday, 23andMe turned five. We’re brimming with vigor and vision. Still a little brash. Conceived with the goal of allowing people to explore their genetic information, 23andMe uses new tools [...]

Read more…

April 26, 2011

Public Comments Due on Possible FDA Regulation of Direct to Consumer Genetic Testing

logopng

From its founding 23andMe has made clear its views that people should have a right to access their own genetic information. And in the debate over regulation of direct to consumer genetic testing, we’ve made our views clear to officials at the Federal Drug Administration (FDA). Have you? May 2nd [...]

Read more…

April 20, 2011

Call to Participate in a New Study on Social Networking and Personal Genomics

social-network

Invitation to Participate in New Research Project -- Social Networking and Personal Genomics: Emerging Issues For Health Research Do you share your information with others? How has your personal genetic information influenced your lifestyle and the way you approach your health and medical decisions? Can [...]

Read more…

April 15, 2011

23andMe Launches Health Report on Alzheimer’s Disease

elderly

Alzheimer’s disease is the most common form of dementia in older people and is projected to become a major health burden as the population of the United States ages. Currently more than five million Americans are thought to have the disease, but by the year 2050 that number is estimated to reach 15 million. [...]

Read more…

Return to top